What is an ependymoma?

An ependymoma (pronounced e-pen-da-moma) is a type of tumour of the brain and spinal cord. Ependymomas belong to a group of tumours called gliomas. An ependymoma is a rare type of glioma.

Gliomas are made up of cells that look similar to cells called glial cells. Glial cells are the supporting celling in the brain and spinal cord. There are different types of glial cells. 

An ependymoma is made up of cells that look like a type of glial cell called ependymal cells. These cells line the fluid-filled spaces (ventricles) in the brain and the centre of the spinal cord. This type of tumour can develop in any part of the brain or spine.

An ependymoma can develop at any age. This information is about ependymomas in adults. The Children’s Cancer and Leukaemia Group has more information on caring for children with cancer, including brain tumours. The The Brain Tumour Charity also has information about brain tumours in children.

Related pages

Symptoms of an ependymoma

Symptoms will depend on the size and position of the tumour and whether the tumour is in the spinal cord or the brain. Ependymomas are often slow growing. Symptoms may develop slowly over many months.

Symptoms may happen if a tumour presses on or grows into nearby areas of the brain or spinal cord. This can stop that part of the brain from working normally.

If the tumour is in the spinal cord, the first symptoms are usually:

  • pain in the neck or back
  • difficulty walking
  • numbness or weakness in the arms
  • problems with bladder control.

If the tumour is in the brain, the first symptoms of an ependymoma may be caused by the tumour causing increased pressure in the skull. This is called raised intracranial pressure.

Symptoms include:

  • headaches
  • feeling or being sick
  • problems with coordination and balance
  • problems with sight
  • seizures (fits)
  • being confused and problems with speech
  • changes in mood and personality, but this is rare.

The tumour may also cause other symptoms, depending on which part of the brain is affected.

We have more information about possible symptoms of a brain tumour.

Related pages

Causes of ependymoma

The causes of ependymomas are unknown, but research is being done to find out more.

In a small number of people, ependymoma is linked to an inherited (genetic) condition called neurofibromatosis type 2 (NF2).

We have more information about risk factors and causes of brain tumours.

Diagnosis of ependymoma

Your doctors need to find out as much as possible about the type, position and size of the tumour so they can plan your treatment.

You will usually have brain scans to find out the exact position and size of the tumour. You may have a brain CT scan first. You also usually have an MRI brain scan. You may have an MRI of both the brain and the spine.

Having an MRI scan is important as it can give more detailed information. If you are not able to have an MRI scan, your doctor will discuss this with you.

There are different types of MRI scans. You may need to have more than 1 to ensure that your doctors have all of the information they need to make a diagnosis and guide any treatment. 

We have more information on the different types of MRI scans used to diagnose brain tumours.

Biopsy

You may also have a biopsy, which involves an operation to take a sample of the tumour to test. Brain tumour biopsies are usually done at the same time as surgery to remove the tumour.

You may also have a lumbar puncture, to collect a small sample of cerebrospinal fluid (CSF) to test.

Your doctor may also:

  • do a physical examination of parts of your nervous system, such as checking your reflexes and the power and feeling in your arms and legs 
  • shine a light at the back of your eye to check if there is swelling
  • ask you some questions to check your reasoning and memory
  • arrange for you to have blood tests to check your general health.

Molecular markers for ependymomas

A doctor who specialises in examining brain tissue samples called a neuro-pathologist looks at the tumour sample under a microscope. This is to find out how fast the tumour is likely to grow. Molecular tests are also done on the sample to look for genetic changes (mutations) in the tumour cells.

Your doctor will use this information to understand how quickly a tumour might grow and to help plan your treatment.

Molecular marker (biomarker) tests

Molecular marker tests are often done on samples removed from the tumour during surgery. They are also called biomarker tests. The samples may be tested for changes in the genes in the tumour cells. Genes are inside every cell. They are the instructions the cell needs to work properly. Sometimes the structure inside a gene is permanently changed and no longer gives the correct instructions. This change is called a gene mutation. Molecular markers tests also look for certain tumour markers or proteins in the tumour.

Molecular markers can give doctors information about:

  • the type of brain tumour
  • help confirm a diagnosis
  • how the tumour may behave in the future
  • which treatment is likely to be the most effective.

Types of ependymomas

There are different types of ependymomas. Your doctor may also describe an ependymoma by the type:

  • Supratentorial ependymoma (STE)

    A grade 2 or 3 tumour – can be described as ZFTA or YAP1 fusion positive.

  • Posterior fossa ependymoma

    A grade 2 or 3 tumour - can be described as PFA or PFB.

  • Spinal ependymoma

    A grade 2 or 3 tumour – with or without MYCN amplification.

  • Myxopapillary ependymoma

    A grade 2 tumour.

  • Subependymoma

    A grade 1 tumour.

Depending on initial results further molecular tests may be done on the same sample to look for other gene changes. In some cases, different results in molecular markers may change the type of treatment you are offered.

You may have to wait some time for the results of these tests. Your doctor can tell you more about molecular tests and if they might be helpful in your situation.

Grading of ependymoma

Your tumour may not be given a grade. This is because your doctor may feel that the molecular tests provide more information. Your doctor can explain more about this.

The grade of a tumour describes how abnormal the cells look under a microscope. This can help your doctor understand how quickly a tumour might grow and whether it is likely to spread to other parts of the brain or spinal cord. They can use this information to help plan your treatment.

Gliomas are usually graded from 1 to 4. But there are only the following 3 grades for ependymomas:

  • Grade 1 and 2 tumours are low-grade, slow growing tumours.
  • Grade 3 are higher-grade, faster growing tumours. 

Treatment for ependymoma

The main treatments for ependymomas are surgery and sometimes radiotherapy. Your treatment depends on the:

  • size and position of the tumour
  • type of the tumour - this includes the grade and molecular markers
  • symptoms you have.

A team of specialists will plan your treatment. Your specialist doctor and nurse will explain the aims of your treatment and what it involves. They will talk to you about the benefits and risks of different treatment types. They will also explain the side effects.

You may be given a choice of treatment options. You will have time to talk about this with your hospital team before you make any treatment decisions.

You will need to give permission (consent) for the hospital staff to give you the treatment. Ask any questions about anything you do not understand or feel worried about. Tell your specialist if you need more information or more time to decide on a treatment.

Surgery

Surgery is the main treatment for an ependymoma. The aim of the surgery is to remove as much of the tumour as safely possible. Some types of ependymoma that can be completely removed do not usually need any other treatment.

We have more information about what to expect before and after surgery.

Radiotherapy

You may also have radiotherapy treatment if: 

  • the tumour has not been completely removed
  • it is a type of ependymoma that is more likely to come back (recur).

Radiotherapy uses high-energy x-rays to destroy the tumour cells and control the tumour.

You may have radiotherapy:

  • after surgery, if the tumour cannot be completely removed
  • after surgery if you have a faster growing ependymoma, to reduce the risk of it coming back
  • as your main treatment, if surgery is not possible.

We have more information about coping with side effects of radiotherapy.

Chemotherapy

Chemotherapy uses anti-cancer drugs to destroy tumour cells. Chemotherapy is rarely used to treat ependymoma in adults. But sometimes doctors may suggest having chemotherapy if the tumour comes back.

We have more information about coping with side effects of chemotherapy.

Side effects of treatment for ependymomas

Your specialist doctor or nurse will explain your treatment and possible side effects. Most side effects are short term and will improve gradually when the treatment is over. Some treatments can cause side effects that may continue and do not always get better. These are called long-term effects. You may also get side effects that may start months or years later. These are called late effects.

Treatment for symptoms of ependymoma

You may need treatment for the symptoms of an ependymoma before you have any treatment for the tumour. You may also need your symptoms managed during your main treatment after it has finished. 

You may have the following treatments:

  • Drugs called anti-convulsants or anti-epileptic drugs (AEDs), to reduce the risk of seizures.
  • Steroids to reduce swelling around the tumour
  • Surgery to drain fluid from the brain to another area of the body to reduce pressure inside the skull. This might be with an operation called endoscopic third ventriculostomy (ETV). It involves putting in a thin tube called an endoscope into the brain. This helps create a new channel to bypass the blockage of the cerebrospinal fluid (CSF).

Sometimes a brain tumour cannot be removed or may stop responding to treatment. If this happens you can still have treatment for any symptoms you may have. You will have supportive care (sometimes called palliative care) from a specialist doctor or nurse who is an expert at managing symptoms and providing emotional support.

We have more information about coping with advanced cancer.

Clinical trials

Clinical trials are a type of medical research involving people. They are important because they show which treatments are most effective and safe. This helps healthcare teams plan the best treatment for the people they care for.

Trials may test how effective a new treatment is compared to the current treatment used. Or they may get information about the safety and side effects of treatments.

They will give you information about the clinical trial so that you understand what it means to take part. If you decide not to take part in a trial, your specialist doctor and nurse will respect your decision. You do not have to give a reason for not taking part. Your decision will not change your care. Your doctor will give you the standard treatment for the type of tumour you have.

Clinical trials also research other areas. These include diagnosis and managing side effects or symptoms. As these tumours are rare, there may not always be a relevant clinical trial happening. If there is, your doctor or nurse may ask you to think about taking part.

We have more information about clinical trials.

After ependymoma treatment

After your treatment has finished, you will have regular check-ups, tests and scans. How often you are seen and for how long may vary depending the size and type of tumour and any treatment you may have had. Appointments are usually more frequent to begin with.

You may continue to have some side effects from treatment. These may include tiredness, or problems with processing thoughts and ideas.

Some side effects can start months or years after treatment has finished. You can use your follow-up appointments to talk about these side effects, or about any other worries or problems you have. Your doctor or nurse may refer you to a neurological rehabilitation (neuro-rehab) service. This service may be able to refer you to a physiotherapist, speech and language therapist or occupational therapist and offer emotional support.

If you have any symptoms or side effects you are worried about, you can also contact your doctor or nurse between appointments.

Many people find they get anxious before appointments. This is natural. It may help to get support from family, friends or a specialist nurse.

How diagnosis affects your right to drive

Following diagnosis and treatment for a brain tumour, most people will not be allowed to drive for a period of time. If you drive, it is important to discuss with your doctor how your diagnosis and treatment for a brain tumour affects your right to drive.

If you have a driving licence, you must tell the licencing agency (DVLA or DVA) that you have been diagnosed with a brain tumour. We have more information about how a brain tumour may affect your right to drive.

Getting support

Being diagnosed with a brain tumour may cause a range of different emotions. There is no right or wrong way to feel. It may help to get support from family, friends or a support organisation.

Macmillan is also here to support you. If you would like to talk, you can:

Other organisations who can help

You may also want to get support from a brain tumour charity, such as:

About our information

This information has been written, revised and edited by Macmillan Cancer Support’s Cancer Information Development team. It has been reviewed by expert medical and health professionals and people living with cancer.

  • References

    Below is a sample of the sources used in our information about ependymoma. If you would like more information about the sources we use, please contact us at informationproductionteam@macmillan.org.uk

     

    Ependymoma: Evaluation and Management. 2022. Available from: www.ncbi.nlm.nih.gov/pmc/articles/PMC9249684/ [accessed June 2024]

     

    Neuro Oncol. 2018. European Association of Neuro-Oncology (EANO) guidelines for the diagnosis and treatment of ependymal tumors. Roberta Rudà et al. Available from: pubmed.ncbi.nlm.nih.gov/29194500/ [accessed June 2024]

     

    European Association of Neuro-Oncology and European Society for Medical Oncology (EANO-ESMO) Clinical Practice Guidelines for prophylaxis, diagnosis, treatment and follow-up: Neurological and vascular complications of primary and secondary brain tumours. 2021. Available from: Available from www.annalsofoncology.org/article/S0923-7534(20)43146-1/fulltext [accessed June 2024].

     

    European Association of Neuro-Oncology (EANO) guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Michael Weller et al. Nature Reviews Clinical Oncology. Published: March 2022. Available from: www.nature.com/articles/s41571-022-00623-3 [accessed June 2024]

     

    NICE Guideline NG99. Brain tumours (primary) and brain metastases in over 16s. 2018 (updated 2021). Available from: www.nice.org.uk/guidance/ng99 [accessed June 2024].

Professor Catherine McBain, Consultant Clinical Oncologist & Honorary Professor in Cancer Sciences

Professor Catherine McBain

Reviewer

Consultant Clinical Oncologist

Date reviewed

Reviewed: 01 May 2024
|
Next review: 01 May 2027
Trusted Information Creator - Patient Information Forum
Trusted Information Creator - Patient Information Forum

Our cancer information meets the PIF TICK quality mark.

This means it is easy to use, up-to-date and based on the latest evidence. Learn more about how we produce our information.

The language we use


We want everyone affected by cancer to feel our information is written for them.


We want our information to be as clear as possible. To do this, we try to:

  • use plain English
  • explain medical words
  • use short sentences
  • use illustrations to explain text
  • structure the information clearly
  • make sure important points are clear.

We use gender-inclusive language and talk to our readers as ‘you’ so that everyone feels included. Where clinically necessary we use the terms ‘men’ and ‘women’ or ‘male’ and ‘female’. For example, we do so when talking about parts of the body or mentioning statistics or research about who is affected.


You can read more about how we produce our information here.